Systemic Lupus Erythematosus - Global Clinical Trials Review, 2025

Description

List of Tables

GlobalData's clinical trial report, "Systemic Lupus Erythematosus - Global Clinical Trials Review, 2025" provides an overview of Systemic Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7253CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Systemic Lupus Erythematosus Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Systemic Lupus Erythematosus
Jun 18, 2025: HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
Jun 12, 2025: Dapirolizumab Pegol Phase 3 Data in SLE Presented at the EULAR Show Improvement in Fatigue and Reduction in Disease Activity
Jun 12, 2025: EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 12, 2025: Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 11, 2025: Fate Therapeutics Announces Clinical Data for FT819 CAR T-cell Demonstrating Durability of Drug-free Remission for Lupus Nephritis at EULAR 2025
May 28, 2025: Resolve Therapeutics and Duke Medical School Initiate Observational Study of Cell-Free RNA in Polytrauma Patients
May 28, 2025: Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
May 22, 2025: Ventus Therapeutics To Present Phase 1 Results for VENT-03, a First-In-Class cGAS Inhibitor, at LUPUS 2025
May 21, 2025: Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with CLE and SLE with Active Lupus Rash
May 06, 2025: Early Clinical Study of UTAA91 Injection in the Treatment of Refractory Autoimmune Diseases
Apr 28, 2025: Kangpu Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
Apr 14, 2025: Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe SLE
Apr 01, 2025: Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7253CTIDB

List of Table

List of Tables

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2025*
Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Systemic Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*

List of Figure

List of Figures

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region (%), 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2025*
Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2025*
Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase (%), 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Systemic Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*
GlobalData Methodology

Systemic Lupus Erythematosus - Global Clinical Trials Review, 2025

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures